A. Magee

发表

The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.

H. Lui, J. Shapiro, W. Gulliver, 2001, Journal of the American Academy of Dermatology.

Subcutaneously Administered Efalizumab (Anti-CD 11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis

A. Gottlieb, B. Miller, P. Walicke, 2003 .

Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis

A. Gottlieb, B. Miller, P. Walicke, 2003, Journal of cutaneous medicine and surgery.

Assessment of Functionality in Elderly Patients When Determining Appropriate Treatment for Nonmelanoma Skin Cancers.

E. McBurney, N. Lawrence, Divya Srivastava, 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].